257 related articles for article (PubMed ID: 21118496)
1. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer.
Langer W; Sohler F; Leder G; Beckmann G; Seidel H; Gröne J; Hummel M; Sommer A
BMC Genomics; 2010 Nov; 11():676. PubMed ID: 21118496
[TBL] [Abstract][Full Text] [Related]
2. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
3. A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data.
Fan W; Khalid N; Hallahan AR; Olson JM; Zhao LP
Theor Biol Med Model; 2006 Apr; 3():19. PubMed ID: 16603076
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation.
Ha KCh; Coulombe-Huntington J; Majewski J
BMC Genomics; 2009 Nov; 10():519. PubMed ID: 19909511
[TBL] [Abstract][Full Text] [Related]
5. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.
Xi L; Feber A; Gupta V; Wu M; Bergemann AD; Landreneau RJ; Litle VR; Pennathur A; Luketich JD; Godfrey TE
Nucleic Acids Res; 2008 Nov; 36(20):6535-47. PubMed ID: 18927117
[TBL] [Abstract][Full Text] [Related]
6. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer.
Misquitta-Ali CM; Cheng E; O'Hanlon D; Liu N; McGlade CJ; Tsao MS; Blencowe BJ
Mol Cell Biol; 2011 Jan; 31(1):138-50. PubMed ID: 21041478
[TBL] [Abstract][Full Text] [Related]
7. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC
J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.
Pio R; Blanco D; Pajares MJ; Aibar E; Durany O; Ezponda T; Agorreta J; Gomez-Roman J; Anton MA; Rubio A; Lozano MD; López-Picazo JM; Subirada F; Maes T; Montuenga LM
BMC Genomics; 2010 Jun; 11():352. PubMed ID: 20525254
[TBL] [Abstract][Full Text] [Related]
10. A statistical framework for genome-wide discovery of biomarker splice variations with GeneChip Human Exon 1.0 ST Arrays.
Yoshida R; Numata K; Imoto S; Nagasaki M; Doi A; Ueno K; Miyano S
Genome Inform; 2006; 17(1):88-99. PubMed ID: 17503359
[TBL] [Abstract][Full Text] [Related]
11. Discovery of tissue-specific exons using comprehensive human exon microarrays.
Clark TA; Schweitzer AC; Chen TX; Staples MK; Lu G; Wang H; Williams A; Blume JE
Genome Biol; 2007; 8(4):R64. PubMed ID: 17456239
[TBL] [Abstract][Full Text] [Related]
12. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
13. The comparison of different pre- and post-analysis filters for determination of exon-level alternative splicing events using Affymetrix arrays.
Whistler T; Chiang CF; Lin JM; Lonergan W; Reeves WC
J Biomol Tech; 2010 Apr; 21(1):44-53. PubMed ID: 20357982
[TBL] [Abstract][Full Text] [Related]
14. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
15. Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells.
Chang JG; Yang DM; Chang WH; Chow LP; Chan WL; Lin HH; Huang HD; Chang YS; Hung CH; Yang WK
PLoS One; 2011; 6(6):e18643. PubMed ID: 21694768
[TBL] [Abstract][Full Text] [Related]
16. L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma.
Wang T; Fan L; Watanabe Y; McNeill P; Fanger GR; Persing DH; Reed SG
Oncogene; 2001 Nov; 20(53):7699-709. PubMed ID: 11753648
[TBL] [Abstract][Full Text] [Related]
17. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.
Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J
PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants.
Chen P; Lepikhova T; Hu Y; Monni O; Hautaniemi S
Nucleic Acids Res; 2011 Oct; 39(18):e123. PubMed ID: 21745820
[TBL] [Abstract][Full Text] [Related]
19. A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples.
Risueño A; Roson-Burgo B; Dolnik A; Hernandez-Rivas JM; Bullinger L; De Las Rivas J
BMC Genomics; 2014 Oct; 15(1):879. PubMed ID: 25297679
[TBL] [Abstract][Full Text] [Related]
20. RNA sequencing and transcriptome arrays analyses show opposing results for alternative splicing in patient derived samples.
Nazarov PV; Muller A; Kaoma T; Nicot N; Maximo C; Birembaut P; Tran NL; Dittmar G; Vallar L
BMC Genomics; 2017 Jun; 18(1):443. PubMed ID: 28587590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
